Zacks Company Profile for EssilorLuxottica Unsponsored ADR (ESLOY : OTC) |
|
|
|
Company Description |
EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France.
Number of Employees: 196,754 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $155.20 |
Daily Weekly Monthly
 |
20 Day Moving Average: 33,373 shares |
Shares Outstanding: 926.29 (millions) |
Market Capitalization: $143,760.36 (millions) |
Beta: 1.06 |
52 Week High: $160.70 |
52 Week Low: $112.95 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
0.96% |
-0.82% |
12 Week |
12.04% |
1.77% |
Year To Date |
28.62% |
15.65% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Francesco Milleri - Chief Executive Officer and Chairman
Paul du Saillant - Deputy Chief Executive Officer
Jean-Luc Biamonti - Chairman
Stefano Grassi - Director
Swati A. Piramal - Director
|
|
Peer Information
EssilorLuxottica Unsponsored ADR (BJCT)
EssilorLuxottica Unsponsored ADR (CADMQ)
EssilorLuxottica Unsponsored ADR (APNO)
EssilorLuxottica Unsponsored ADR (UPDC)
EssilorLuxottica Unsponsored ADR (IMTIQ)
EssilorLuxottica Unsponsored ADR (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 297284200
SIC: 8880
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 926.29
Most Recent Split Date: (:1)
Beta: 1.06
Market Capitalization: $143,760.36 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 1.04% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $1.62 |
Current Fiscal Year EPS Consensus Estimate: $4.08 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 3.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: 7.69% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: - |
|
|
|
|